Abridge
Healthcare AI
Valuation
$5.3B (2025)
Total Funding
$460M+
Profit Status
Pre-profit, rapid growth
Employees
~400
About Abridge
Abridge is a healthcare AI company that uses generative AI to convert patient-clinician conversations into structured clinical notes in real time, integrated directly into electronic health records like Epic. It reduces physician documentation burden and burnout, and is deployed across many of the largest US health systems. Reached a $5.3B valuation in 2025.
Company History
Founded 2018 by cardiologist Shiv Rao. Pioneered ambient AI documentation for clinicians, deeply integrated with Epic. Adoption accelerated across major US health systems (Kaiser Permanente, UPMC, Mayo Clinic). Raised $150M Series C (Feb 2024), $250M Series D at $2.75B (Feb 2025), then a round at $5.3B valuation (Jun 2025) led by Andreessen Horowitz. One of the fastest-scaling healthcare AI companies.
Company Timeline
2018
Founded by cardiologist Shiv Rao
Feb 2024
$150M Series C; deep Epic integration
Feb 2025
$250M Series D at $2.75B valuation
Jun 2025
Raises at $5.3B valuation led by a16z
Products & Services
Company Details
Focus Area
Healthcare AI
Stage
Founded
2018
Headquarters
Pittsburgh, PA
Employees
~400
Financial Overview
Total Funding
$460M+
Valuation
$5.3B (2025)
Profit Status
Pre-profit, rapid growth
Funding Rounds
- Series C$150MFeb 2024Lightspeed, Redpoint
- Series D$250MFeb 2025IVP, Elad Gil
- Series E$300MJun 2025Andreessen Horowitz, Khosla Ventures
Key Investors
Key People
- Shiv Rao (CEO, co-founder)
- Zachary Lipton (Chief Scientific Officer)